NANOBIO CORPORATION
734-302-4000
2311 Green Rd, Suite A
Ann Arbor, Michigan
48105-2966
, USA
Fax: 734-302-9150
Website Links: NANOBIO CORPORATION | $6.3M Gates Foundation... | Anti-infectives | BenefitsProgram | Conferences | Daniel B. Dubin, MD Joins... | David M. Stout Joins... | David Peralta Joins NanoBio... | Dept. of Defense Awards... | Dermatology | Director of Clinical... | Dr. Robert C. Moellering,... | Easy-to-use nasal anthrax... | FierceBiotech Names NanoBio... | Jay Birnbaum, Ph.D.,... | Jerald C. Sadoff, MD... | Joyce Sutcliffe, PhD,... | NanoBio 2008 ICAAC /... | NanoBio Announces Closing... | NanoBio Corporation Announces...
Contract References
- DAAD1303C0079 - ARMY, DEPT THE (EXC CORPS OF ENGINEERS CIVIL PROGRAM FIN)
| Business Type | Service |
| Ownership | Veteran owned |
Web Site Results
- NanoBio Corporation
- Home | Contact Us | Site Map Company PlatformTech Dermatology Anti-infectives Vaccines News Recent News: July 8, 2009 NanoBio Announces Closing of $22 Million Series B Financing Round May 6, 2009 NanoBio to Announce Key Preclinical
- Three New Patents Awarded
- Home | Contact Us | Site Map Company PlatformTech Dermatology Anti-infectives Vaccines News PressReleases Publications Conferences Three New Patents Awarded for NanoBio Corporation's Antimicrobial Nanoemulsion Technology Ann Arbor, Michigan USA (January 29, 2004)
- Dept. of Defense Awards...
- Home | Contact Us | Site Map Company PlatformTech Dermatology Anti-infectives Vaccines News PressReleases Publications Conferences Department of Defense Awards $3.2 Million Contract to NanoBio Corporation Ann Arbor, Michigan USA (December 16 2003) NanoBio
- NanoBio Corporation - Press Releases
- Home | Contact Us | Site Map Company PlatformTech Dermatology Anti-infectives Vaccines News PressReleases Publications Conferences Media Contact: Stacey Holifield/Laura Coluci Schwartz Communications nanobio@schwartz-pr.com (781) 684-0770 NanoBio in
- NanoBio Announces Closing...
- Home | Contact Us | Site Map Company PlatformTech Dermatology Anti-infectives Vaccines News PressReleases Publications Conferences NanoBio Announces Closing of $22 Million Series B Financing Round Funds Will Support Clinical Trials and Ongoing Operations